EAGLE PHARMACEUTICALS INC's ticker is and the CUSIP is 269796908. A total of 2 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11 | – | 400 | -20.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $24,000 | -87.2% | 500 | -86.5% | 0.00% | – |
Q4 2021 | $188,000 | +469.7% | 3,700 | +46150.0% | 0.00% | – |
Q3 2020 | $33,000 | 0.0% | 8 | +14.3% | 0.00% | – |
Q2 2020 | $33,000 | +725.0% | 7 | +600.0% | 0.00% | – |
Q1 2020 | $4,000 | -99.9% | 1 | -99.9% | 0.00% | -100.0% |
Q4 2019 | $5,064,000 | +151.6% | 843 | +136.8% | 0.01% | +83.3% |
Q3 2019 | $2,013,000 | -30.5% | 356 | -31.5% | 0.01% | -25.0% |
Q2 2019 | $2,895,000 | +106.3% | 520 | +87.1% | 0.01% | +100.0% |
Q1 2019 | $1,403,000 | +793.6% | 278 | +612.8% | 0.00% | – |
Q4 2018 | $157,000 | -95.5% | 39 | -92.3% | 0.00% | -100.0% |
Q3 2018 | $3,515,000 | +36.7% | 507 | +49.1% | 0.01% | +10.0% |
Q2 2018 | $2,572,000 | +85633.3% | 340 | +62.7% | 0.01% | – |
Q1 2018 | $3,000 | -72.7% | 209 | +161.2% | 0.00% | – |
Q4 2017 | $11,000 | -78.4% | 80 | -20.8% | 0.00% | -100.0% |
Q3 2017 | $51,000 | +15.9% | 101 | -34.4% | 0.00% | 0.0% |
Q2 2017 | $44,000 | +25.7% | 154 | +396.8% | 0.00% | 0.0% |
Q1 2017 | $35,000 | -64.3% | 31 | -59.7% | 0.00% | -66.7% |
Q4 2016 | $98,000 | -54.6% | 77 | -66.4% | 0.01% | -60.0% |
Q3 2016 | $216,000 | +332.0% | 229 | -1.3% | 0.02% | +400.0% |
Q2 2016 | $50,000 | -20.6% | 232 | +149.5% | 0.00% | -40.0% |
Q1 2016 | $63,000 | +1475.0% | 93 | +745.5% | 0.01% | – |
Q4 2015 | $4,000 | -84.6% | 11 | -81.7% | 0.00% | -100.0% |
Q3 2015 | $26,000 | +2500.0% | 60 | +1900.0% | 0.00% | – |
Q2 2015 | $1,000 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 229 | $216,000 | 0.02% |
GROUP ONE TRADING, L.P. | 200 | $14,000 | 0.00% |